Item 8.01 Other Information
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press release datedJanuary 18, 2022 , titled "PolarityTE AnnouncesU.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication." 104 Cover Page Interactive Data File, formatted in Inline XBRL
© Edgar Online, source